Adjuvant FGFR3 Inhibition in Bladder Cancer

News Center

ARTICLES

Adjuvant FGFR3 Inhibition in Bladder Cancer

PRACTICE UPDATE

PUBLISHED: 22 FEBRUARY 2020

Adjuvant FGFR3 Inhibition in Bladder Cancer

explore_now-footer.png


Published

February 22, 2020

Categories

CP-202103 -
J-C Health Care Ltd. – Janssen Israel, Kibbutz Sheffayim 6099000, fax 09-9583636 info-janssen@its.jnj.com
OneTrust Privacy Policyמידע משפטי
Logo